{
    "organizations": [],
    "uuid": "f248e343f2ab58c6e8360451f75dcc31704bc097",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-symbio-pharmaceuticals-initiated-p/brief-symbio-pharmaceuticals-initiated-phase-1-study-in-japan-for-oral-treakisym-in-patients-with-progressive-solid-tumors-idUSFWN1PE1CO",
    "ord_in_thread": 0,
    "title": "BRIEF-Symbio Pharmaceuticals ‍initiated Phase 1 Study in Japan for Oral Treakisym in patients with progressive solid tumors​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 21 (Reuters) - Symbio Pharmaceuticals Ltd:\n* ‍HAS INITIATED A PHASE 1 STUDY IN JAPAN FOR ORAL TREAKISYM IN PATIENTS WITH PROGRESSIVE SOLID TUMORS​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-01-22T07:35:00.000+02:00",
    "crawled": "2018-01-22T20:41:52.024+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "symbio",
        "pharmaceutical",
        "ltd",
        "initiated",
        "phase",
        "study",
        "japan",
        "oral",
        "treakisym",
        "patient",
        "progressive",
        "solid",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}